AKESO (09926.HK) Stock Community - Hot Topic Discussions

Quote List Quote List

Event Tracking

Nov13

CITIC Securities Issues Positive Report on CanAngela's Pipeline

08:49

Nov10

Competition Between Kangkang Biotech and Ssan Pharmaceutical in PD-1/VEGF Bispecific Antibodies

04:30

Nov7

Akeso Announces Significant OS Improvement in Ivonescimab Study

18:27

Nov3

Kangkang Biotech's Ivonescimab Receives Breakthrough Therapy Designation for TNBC

04:17

Oct30

CanSino Biologics Announces Final Overall Survival Check Results of HARMONi-A Study

15:22

Oct24

HSBC Raises Target Price for Kangley Biotech to HKD 207 and Maintains Buy Rating

07:12

Schedules & Filings

Schedules

Filings

Aug26

Earning Release(CST)

FY2025 Q2 Earning Release (HKD) Revenue 772.48 M, Net Income -311.98 M, EPS -0.3502

Mar30

Earning Release(CST)

FY2024 Q4 Earning Release (HKD) Revenue 584.69 M, Net Income -146.77 M, EPS -0.1712

Aug28

Earning Release(CST)

FY2024 Q2 Earning Release (HKD) Revenue 550.56 M, Net Income -128.19 M, EPS -0.1517

Stock List

Top Gainers

Top Decliners

Main Board

Symbol

Price

%Chg

Change